89 results
8-K
EX-99.1
BFRI
Biofrontera Inc
15 May 24
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
5:20pm
due to the Change Healthcare data breach
Cash and cash equivalents were $3.8 million as of March 31, 2024, compared with $1.3 million on December 31 … , 2023
The Company completed a private placement of preferred stock with healthcare focused institutional investors for gross proceeds of $8 million
Met
8-K
EX-99.1
BFRI
Biofrontera Inc
3 May 24
Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants
9:15am
the Company’s ability to obtain and distribute its licensed products; changes in the practices of healthcare providers, including any changes
8-K
EX-99.1
BFRI
Biofrontera Inc
26 Mar 24
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
4:45pm
disruptions in supply chains will impact the Company’s ability to obtain and distribute its licensed products; changes in the practices of healthcare
8-K
EX-99.1
sof6iug
15 Mar 24
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
5:20pm
8-K
EX-10.1
t2tc40
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
8-K
EX-99.1
xa42ft1qoh hvi2cz
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
8-K
EX-99.2
q3k8gycq2rm6xe1siqw
20 Feb 24
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
9:37am
8-K
EX-99.1
buytt5
20 Feb 24
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
9:37am
8-K
ntrwftmk
20 Feb 24
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
9:37am
8-K
EX-99.1
w3os 6gcr
5 Feb 24
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz® to Permit Up to Three Tubes per Use
5:25pm
8-K
EX-99.1
msfc1bwxqz78ivnt r9
11 Jan 24
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023
4:40pm
8-K
EX-99.1
5sr52zk1sqnu4eo
9 Nov 23
Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update
5:15pm